Halozyme Therapeutics Inc
NASDAQ:HALO

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
NASDAQ:HALO
Watchlist
Price: 71.67 USD -1.04% Market Closed
Market Cap: 8.4B USD

Intrinsic Value

The intrinsic value of one HALO stock under the Base Case scenario is hidden USD. Compared to the current market price of 71.67 USD, Halozyme Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

HALO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Halozyme Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

HALO looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if HALO is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about HALO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HALO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Halozyme Therapeutics Inc.

Explain Valuation
Compare HALO to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HALO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Halozyme Therapeutics Inc

Current Assets 1.3B
Cash & Short-Term Investments 702m
Receivables 346m
Other Current Assets 280.8m
Non-Current Assets 892.5m
PP&E 71.4m
Intangibles 765.4m
Other Non-Current Assets 55.7m
Current Liabilities 837.2m
Accounts Payable 15.4m
Accrued Liabilities 111.2m
Other Current Liabilities 710.7m
Non-Current Liabilities 880.1m
Long-Term Debt 800.1m
Other Non-Current Liabilities 80m
Efficiency

Free Cash Flow Analysis
Halozyme Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Halozyme Therapeutics Inc

Revenue
1.2B USD
Cost of Revenue
-192.1m USD
Gross Profit
1.1B USD
Operating Expenses
-313.4m USD
Operating Income
737.4m USD
Other Expenses
-141.9m USD
Net Income
595.5m USD
Fundamental Scores

HALO Profitability Score
Profitability Due Diligence

Halozyme Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Exceptional ROIC
Exceptional 3Y Average ROIC
hidden
Profitability
Score

Halozyme Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

HALO Solvency Score
Solvency Due Diligence

Halozyme Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Halozyme Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HALO Price Targets Summary
Halozyme Therapeutics Inc

Wall Street analysts forecast HALO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HALO is 77.52 USD with a low forecast of 56.56 USD and a high forecast of 96.6 USD.

Lowest
Price Target
56.56 USD
21% Downside
Average
Price Target
77.52 USD
8% Upside
Highest
Price Target
96.6 USD
35% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Halozyme Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HALO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HALO Insider Trading
Buy and sell transactions by insiders

HALO News

Other Videos
What is the Intrinsic Value of one HALO stock?

The intrinsic value of one HALO stock under the Base Case scenario is hidden USD.

Is HALO stock undervalued or overvalued?

Compared to the current market price of 71.67 USD, Halozyme Therapeutics Inc is hidden .

Back to Top